Relay Therapeutics

📍 Cambridge, United States🗓 Founded 2016👥 337 employees💰 Last funded Dec 2017
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology. By applying these insights, we believe we have a differentiated approach to drug protein targets based on their motion, enabling us to select and advance unique product candidates that can be developed into novel therapies for patients. Located in Cambridge, Massachusetts, our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. If you're creative, collaborative and passionate about making a difference in the lives of patients, join us!
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Relay Therapeutics?
Relay Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Relay Therapeutics last raise funding?
The most recent investment in Relay Therapeutics recorded on gritt.io was in December 2017.
When was Relay Therapeutics founded?
Relay Therapeutics was founded in 2016.
What industry is Relay Therapeutics in?
Relay Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Relay Therapeutics based?
Relay Therapeutics is headquartered in Cambridge, United States.